CoChat

Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is one of the common long-term degenerative disorders that primarily affect motor systems. Gastrointestinal (GI) symptoms are common in individuals with PD and often present before motor symptoms. It has been found that gut dysbiosis to PD pathology is related to the severity of motor and non-motor symptoms in PD. Probiotics have been reported to have the ability to improve the symptoms related to constipation in PD patients. However, the evidence from preclinical or clinical research to verify the beneficial effects of probiotics for the motor functions in PD is still limited. An experimental PD animal model could be helpful in exploring the potential therapeutic strategy using probiotics. In the current study, we examined whether daily and long-term administration of probiotics has neuroprotective effects on nigrostriatal dopamine neurons and whether it can further alleviate the motor dysfunctions in PD mice. Transgenic MitoPark PD mice were chosen for this study and the effects of daily probiotic treatment on gait, beam balance, motor coordination, and the degeneration levels of dopaminergic neurons were identified. From the results, compared with the sham treatment group, we found that the daily administration of probiotics significantly reduced the motor impairments in gait pattern, balance function, and motor coordination. Immunohistochemically, a tyrosine hydroxylase (TH)-positive cell in the substantia nigra was significantly preserved in the probiotic-treated PD mice. These results showed that long-term administration of probiotics has neuroprotective effects on dopamine neurons and further attenuates the deterioration of motor dysfunctions in MitoPark PD mice. Our data further highlighted the promising possibility of the potential use of probiotics, which could be the relevant approach for further application on human PD subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci10040206

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Experimental design for the identification of long-term effects of probiotic administration in MitoPark Parkinson’s disease (PD) mice (n = 20). Daily administration of probiotics was treated from the age of 8 weeks to 24 weeks in MitoPark PD mice. Behavioral tests, including rotarod, beam balance, and gait analysis, were performed every two weeks to test the time-course effects during treatment. Immunohistochemistry (IHC) analysis was applied at the age of 24 weeks to identify the neuroprotective effects on dopaminergic cells following probiotic intervention.
Figure 1 Experimental design for the identification of long-term effects of probiotic administration in MitoPark Parkinson’s disease (PD) mice (n = 20). Daily administration of probiotics was treated from the age of 8 weeks to 24 weeks in MitoPark PD mice. Behavioral tests, including rotarod, beam balance, and gait analysis, were performed every two weeks to test the time-course effects during treatment. Immunohistochemistry (IHC) analysis was applied at the age of 24 weeks to identify the neuroprotective effects on dopaminergic cells following probiotic intervention.CC BY · PubMed Central
Figure 2 The effect of long-term probiotic administration on balance function (A) and motor coordination (B) evaluated by the beam walking test and rotarod test, respectively. The duration of the elapsed time for the probiotic-treated PD mice was significantly lower than that of the sham-treated PD mice after the age of 14 weeks. In the rotarod test, the latency for the probiotic-treated mice was significantly longer than that of the sham-treated mice after the age of 18 weeks. Values are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, significant differences between two groups.
Figure 2 The effect of long-term probiotic administration on balance function (A) and motor coordination (B) evaluated by the beam walking test and rotarod test, respectively. The duration of the elapsed time for the probiotic-treated PD mice was significantly lower than that of the sham-treated PD mice after the age of 14 weeks. In the rotarod test, the latency for the probiotic-treated mice was significantly longer than that of the sham-treated mice after the age of 18 weeks. Values are presented as the mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, significant differences between two groups.CC BY · PubMed Central
Figure 3 Characteristics of stepping footprints during a 2-sec walkway walking for an 8-week-old MitoPark PD mouse, a 24-week-old MitoPark PD mouse with non-probiotic treatment, and a 24-week-old MitoPark PD mouse with long-term probiotic treatment (A). Time-course changes in walking speed (B), step length (C), stride length (D), step width (E), stance phase time (F), and swing phase time (G) in the sham- and probiotic-treated PD mice over a 16-week observation period. The results showed that the gait function decreases significantly in the sham-probiotic-treated group but decreases less in the probiotic treatment group. * p < 0.05, ** p < 0.01, *** p < 0.001, significant difference between the two groups at each time point.
Figure 3 Characteristics of stepping footprints during a 2-sec walkway walking for an 8-week-old MitoPark PD mouse, a 24-week-old MitoPark PD mouse with non-probiotic treatment, and a 24-week-old MitoPark PD mouse with long-term probiotic treatment (A). Time-course changes in walking speed (B), step length (C), stride length (D), step width (E), stance phase time (F), and swing phase time (G) in the sham- and probiotic-treated PD mice over a 16-week observation period. The results showed that the gait function decreases significantly in the sham-probiotic-treated group but decreases less in the probiotic treatment group. * p < 0.05, ** p < 0.01, *** p < 0.001, significant difference between the two groups at each time point.CC BY · PubMed Central
Figure 4 Representative tyrosine hydroxylase (TH) immunostaining in the substantia nigra pars compacta (SNpc) in PD mouse without probiotic treatment and in PD mouse with probiotic treatment (A). The average numbers of TH-positive neurons in the SNpc between sham treatment and probiotic-treated groups were compared (B). * p < 0.05 (unpaired t-test).
Figure 4 Representative tyrosine hydroxylase (TH) immunostaining in the substantia nigra pars compacta (SNpc) in PD mouse without probiotic treatment and in PD mouse with probiotic treatment (A). The average numbers of TH-positive neurons in the SNpc between sham treatment and probiotic-treated groups were compared (B). * p < 0.05 (unpaired t-test).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 73 references

Cited by

See all 174

Metadata

Authors
Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., Chen, K.-Y., & Chen, H.-Y.
Affiliations
  • Chang Gung University (TW)
  • National Taiwan University (TW)
  • Tajen University (TW)
  • Taipei Medical University (TW)
  • Taichung Veterans General Hospital (TW)
Corresponding author
Chen, Hsin-Yung
Venue
Brain Sciences
Publisher
MDPI AG
Published
2020-04-01
Volume
10
Issue
4
Pages
206
ISSN
2076-3425 (ISSN-L)
OpenAlex
W3014346200
Cited by
174
References
73
Citations by year
2026: 17 · 2025: 27 · 2024: 29 · 2023: 35 · 2022: 33 · 2021: 22 · 2020: 9
FWCI
10.72
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministry of Science and Technology, Taiwan (106-2410-H-182-008-MY2, 108-2314-B-182-011)
  • Chang Gung Memorial Hospital (CMRPD1H0461, CMRPD1H0462, CMRPD1F0501, CMRPD3H0021)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords
probiotics, Parkinson's disease, motor impairment, neuroprotection, dopaminergic neurons, substantia nigra, gut dysbiosis, tyrosine hydroxylase, gait, balance, motor coordination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease. https://app.cochat.ai/papers/10.3390/brainsci10040206
The paper
Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., Chen, K.-Y., & Chen, H.-Y. (2020). Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease. Brain Sciences. https://doi.org/10.3390/brainsci10040206

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.